dr. schmidinger on side effects from targeted agents in renal cell cancer
Published 11 years ago • 1.2K plays • Length 1:47Download video MP4
Download video MP3
Similar videos
-
0:51
dr. schmidinger on managing side effects from targeted therapies in rcc
-
12:43
are side effects predictive of efficacy? manuela schmidinger, m.d.
-
5:06
alternative dosing schedules for targeted agents in renal cell carcinoma
-
0:40
dr. robert dreicer on an alternate sunitinib schedule in metastatic renal cell carcinoma
-
1:21
dr. mckay discusses combinations in renal cell carcinoma
-
1:36
dr. thomas hutson on drug sequencing in renal cell carcinoma
-
1:34
dr. quinn on combinations of targeted therapy in rcc
-
31:14
current treatment of advanced renal cell carcinoma, christian kollmannsberger, md
-
4:15
case review: symptomatic metastatic renal cell cancer
-
8:27
checkpoint inhibition in renal cell carcinoma
-
1:28
dr. braun on evolution of immunotherapy in advanced renal cell carcinoma
-
6:46
treatment considerations in renal cell carcinoma
-
0:45
dr. choueiri on fda approval of lenvatinib/everolimus in rcc
-
3:47
other clinical trials in renal cell carcinoma
-
27:59
outcomes for patients with locally advanced renal cell carcinoma christopher g. wood, m.d., ut
-
0:54
dr. vaishampayan on immunotherapy trials in kidney cancer
-
6:52
nivolumab in renal cell carcinoma
-
3:59
the future of renal cell carcinoma
-
5:49
importance of risk assessment in renal cell carcinoma